The Effectiveness of Health Advice and Occupational Health Intervention on Work Ability

NCT00378989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 418

Last updated 2015-02-10

No results posted yet for this study

Summary

Study hypotheses were 1) Classification of the risk of sickness absence can be made with questionnaires addressing self-rated health problems; 2) Occupational health intervention of the employees at 'High Risk´ of sickness absence is more effective than usual care in controlling sickness absence; 3) Health advice intervention of the employees at 'Increased Risk´ of sickness absence is more effective than usual care in controlling sickness absence; 4) The interventions are cost-effective use of resources from the societal perspective.

Conditions

  • Signs and Symptoms

Interventions

BEHAVIORAL

Consultation at the occupational health services

Consultation at the occupational health services

Sponsors & Collaborators

  • Mutual Pension Insurance Company Ilmarinen

    collaborator UNKNOWN
  • The Finnish Funding Agency for Technology and Innovation (TEKES)

    collaborator OTHER_GOV
  • Sitra, the Finnish Innovation Fund

    collaborator OTHER
  • Pfizer

    collaborator INDUSTRY
  • Finnish Office for Health Technology Assessment, FinOHTA/Stakes

    collaborator UNKNOWN
  • University of Helsinki

    collaborator OTHER
  • Evalua International

    lead OTHER

Principal Investigators

  • Simo P Taimela, MD, PhD · Evalua International

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2005-10-31
Completion
2006-10-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00378989 on ClinicalTrials.gov